- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2019-01-03 20:58:52
- Reporting Period:
- Accepted Time:
- 2019-01-03 20:58:52
- SEC Url:
- Form 4 Filing
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1521548||Michael Halstead||C/o Intra-Cellular Therapies, Inc. |
430 East 29Th Street
New York NY 10016
|Evp And General Counsel||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Restricted Stock Units||Disposition||2019-01-03||5,298||$0.00||5,298||$0.00|
|Common Stock||Restricted Stock Units||Disposition||2019-01-03||16,160||$0.00||16,160||$0.00|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- Represents shares issued upon the vesting of performance stock units.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2018. A majority of the proceeds from this sale will be used to cover the reporting person's tax liability arising from the vesting of performance stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.77 to $11.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Restricted stock units convert into common stock on a one-for-one basis.
- Each restricted stock unit represents a contingent right to receive one share of common stock.
- On January 3, 2017, the reporting person was granted 15,893 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- On January 3, 2018, the reporting person was granted 48,480 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.